Cephalosporins of the third generation for the treatment of gonorrhea

Author:

Frigo N V,Guchev I A,Sidorenko S V,Lesnaya I N,Solomka V S,Frigo N V,Guchev I A,Sidorenko S V,Lesnaya I N,Solomka V S

Abstract

The article presents the data on antibiotic resistance and N. gonorrhoeae mechanisms for developing resistance to antimicrobial drugs belonging to different pharmacologic groups and applied for causal treatment of gonorrhea. The article proves the key problem related to the treatment of gonococcal infection in Russia lies in the prevalence of strains being resistant to most of the antibacterial drugs that used to be applied in the clinical practice on a broad scale and efficiently. So, cephalosporins of the third generation are presently the only drug type that N. gonorrhoeae remains sensitive to. Their application ensures the maximum efficacy against the gonococcal infection. According to the presentday international recommendations complying with the WHO criteria as well as accumulated experience, cefixime, a drug belonging to cephalosporins of the third generation, can be a drug of choice for the antibacterial therapy of gonorrhea along with ceftriaxon.

Publisher

Rossijskoe Obschestvo Dermatovenerologov i Kosmetologov

Reference72 articles.

1. Hook E.W.I., Handsfield H.H. Gonococcal infections in the adult. In: Holmes K.K., Sparling P.F., Stamm W.E. et al., editors. Sex Transmit Dis New York, NY: McGraw-Hill Medical, 2008: 627-45.

2. Ebers Papyrus. From New World Encyclopedia. Available at <http://www.newworldencyclopedia>. org/entry/Ebers_Papyrus.

3. Neisser A.L.S. Ueber eine der Gonorrhoe eigentümliche Micrcoccenform. Centralblatt für die medicinischen Wissenschaften, Berlin 1879 (28): 497-500.

4. Available at: <http://www.cdc.gov/std/stats08/> tables/12.htm. Accessed 17 May 2010.

5. Centers for Disease Control and Prevention. Sexually Transmitted Diseases Treatment Guidelines, 2010. Morbidity and Mortality Weekly Report (MMWR) 2010; 59 (RR-12): 1-114.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3